"For the millions of people who rely on daily injections of insulin for treatment of diabetes, having a biosimilar option for their rapid-acting insulin injection can truly make a difference ...

Instead, it must be delivered into the tissues under the skin. This is most commonly done using insulin injections. Here's what you need to know about using insulin and how to inject it properly.

The QWINT-1 study compared efsitora to daily injections of Sanofi’s SNY Lantus (insulin glargine) for 52 weeks in T2D patients using basal insulin for the first time. The QWINT-3 study compared ...